Skip to main content
Premium Trial:

Request an Annual Quote

Rockefeller University Grants Rosetta Genomics Rights to Study Its microRNAs

NEW YORK (GenomeWeb News) - Rosetta Genomics has licensed from Rockefeller University the right to access nearly 180 of its microRNAs, Rosetta said today.
 
Rosetta said it will add these microRNAs to its existing microRNA database, which could arm it with additional biomarker candidates for its diagnostic development programs.
 
Rosetta has discovered nearly 360 biologically validated human microRNAs and the Rockefeller agreement will enable it to study 530 of the 660 publicly confirmed microRNA genes in the entire human genome, the company said.
 
The company will use the microRNAs to "potentially advance multiple" research development programs targeting new microRNA-based diagnostic tools for a "variety" of diseases.
 
Terms of the agreement call for Rosetta Genomics to pay Rockefeller University an initiation fee as well as maintenance fees and royalties.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.